Cambridge, MA · Founded 2021 · Privately Held (backing)
Developer of a biostaged medicine designed to map the progression of diseases. Etiome is based in Cambridge, MA and was founded in 2021. Its last reported valuation was $144 million in Apr 2025. It has raised $50 million.
Last reported valuation
$144.0M
Oct 2026
Priced at
—
Total raised
$50.0M
Last round
—
Cap table — not yet on record
Etiome's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Etiome with a free account
·Watch Etiome: the Monday email on marks, rounds and moves
